Balyasny Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162M | Sell |
|
|||||
|
2025
Q1 | $185M | Buy |
|
|||||
|
2024
Q4 | $158M | Sell |
|
|||||
|
2024
Q3 | $290M | Buy |
|
|||||
|
2024
Q2 | $225M | Buy |
|
|||||
|
2024
Q1 | $109M | Buy |
|
|||||
|
2023
Q4 | $77M | Buy |
|
|||||
|
2023
Q3 | $400K | Sell |
|
|||||
|
2023
Q2 | $1.02M | Sell |
|
|||||
|
2023
Q1 | $29.7M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $90.9M | Buy |
|
|||||
|
2022
Q2 | $44.1M | Buy |
|
|||||
|
2022
Q1 | $21.1M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $93.5M | Buy |
|
|||||
|
2021
Q2 | $74.1M | Buy |
|
|||||
|
2021
Q1 | – | Hold |
|
|||||
|
2020
Q4 | – | Hold |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $5.2M | Sell |
|
|||||
|
2020
Q1 | $71.1M | Buy |
|
|||||
|
2019
Q4 | $14.8M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $23.7M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $18M | Sell |
|
|||||
|
2018
Q2 | $26M | Buy |
|
|||||
|
2018
Q1 | $3.51M | Sell |
|
|||||
|
2017
Q4 | $23.2M | Sell |
|
|||||
|
2017
Q3 | $28.6M | Sell |
|
|||||
|
2017
Q2 | $52.7M | Buy |
|
|||||
|
2017
Q1 | $1.51M | Sell |
|
|||||
|
2016
Q4 | $1.64M | Sell |
|
|||||
|
2016
Q3 | $58.2M | Sell |
|
|||||
|
2016
Q2 | $62.5M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $15M | Buy |
|
|||||
|
2015
Q3 | $8.08M | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $13.3M | Buy |
|
|||||
|
2013
Q2 | $9.31M | Buy |
|